Rockville, Maryland — October 7, 2026 : New Fact.MR research finds that the global point of care diagnostics market is set to expand from USD 47.8 billion in 2026 to USD 94.1 billion by 2036, advancing at a 7.0% CAGR during the forecast period. The market is expected to create an absolute dollar opportunity of USD 46.3 billion as healthcare providers, government programs, and institutional buyers increase adoption of decentralized diagnostic technologies. Rising chronic disease prevalence, expanding healthcare infrastructure, and growing demand for rapid clinical decision-making are strengthening procurement across hospitals, clinics, ambulatory facilities, and other care settings.

Get detailed market forecasts, competitive benchmarking, and pricing trends: 

A major source of demand is the increasing burden of chronic conditions, particularly diabetes and cardiovascular diseases, which sustains requirements for glucose monitoring, cardiac marker testing, and related point-of-care systems. At the same time, regulatory developments supporting molecular respiratory and infectious disease panels are enabling more testing outside centralized laboratories. Connected diagnostic platforms are also gaining relevance as healthcare organizations seek systems capable of transmitting results to electronic health records and supporting remote clinical review.

Glucose Monitoring Systems dominate the product landscape, accounting for 64.8% of the product segment in 2026. Their leading position reflects established clinical protocols, broad institutional adoption, recurring procurement requirements, and their central role in managing patient glucose levels. Acute Care Diagnostics leads by application with a 58.3% share, while Hospitals & Clinics represent 69.2% of end-use demand, underscoring the importance of institutional healthcare networks in market development.

India represents the fastest-growing country market in the report, with a projected 7.8% CAGR through 2036. Expansion of Ayushman Bharat and National Health Mission procurement is increasing demand for glucose, infectious disease, and cardiac marker testing at primary health centers, while infrastructure gaps in tier-2 and tier-3 cities support demand for portable systems. China follows at 7.6%, supported by hospital modernization programs, provincial procurement tenders, and domestic biosensor manufacturing. Germany is forecast to expand at 7.4%, with EU IVDR compliance requirements, reimbursement considerations, and decentralized primary care models shaping purchasing decisions.

The competitive landscape includes Abbott Laboratories, Hoffmann-La Roche Ltd., Siemens Healthineers, and Danaher Corporation through Beckman Coulter, Cepheid, and Radiometer. Thermo Fisher Scientific, BD, bioMérieux, and QuidelOrtho also participate across different product categories and geographic markets. Abbott Laboratories holds a 33.8% share, according to Fact.MR, supported by broad product coverage, institutional relationships, and geographic reach. Competition is increasingly influenced by clinical performance, regulatory compliance, digital connectivity, and after-sales service capabilities.

Technology integration is creating another avenue for market expansion. Miniaturized biosensors, microfluidic platforms, and molecular amplification technologies are supporting portable multi-analyte systems that can be deployed closer to patients. Multi-analyte cartridges capable of combining respiratory, cardiac, and metabolic testing can increase the value generated from individual testing events, while connected systems support centralized data management and remote monitoring. These developments are particularly relevant as institutional buyers increasingly evaluate total cost of ownership rather than unit pricing alone.

North America continues to account for a leading share of global demand because of established healthcare infrastructure, regulatory clarity, and high healthcare spending. Europe maintains steady demand, with Germany and other markets influenced by compliance requirements and hospital modernization. Meanwhile, Asia Pacific is expanding at a faster pace as India and China increase healthcare capacity through public programs and private investment.

Unlock 360° insights for strategic decision making and investment planning: 

Despite the growth opportunity, manufacturers face challenges related to reimbursement uncertainty, quality assurance in decentralized testing, reagent cold-chain requirements, and infrastructure limitations in remote locations. Suppliers that combine reliable diagnostic performance with digital connectivity, regulatory readiness, and responsive service networks are positioned to address institutional procurement priorities more effectively. Fact.MR’s Point of Care Diagnostics Market report provides detailed forecasts, country-level analysis, segment insights, competitive benchmarking, and growth opportunities through 2036.

Explore More Related Studies Published by Fact.MR Research

Non-Invasive Diagnostic Tests Market

Disposable Spirometry Filters Market

Dual-Chamber Cartridge Plungers Market

Elastomeric Pump Cartridges Market

CPAP Humidifier Chambers Market

About Fact.MR

Fact.MR is a market research and consulting firm providing syndicated research, customized research, investment research, and market intelligence across a broad range of industries. Its research coverage includes food and beverage, healthcare, pharmaceuticals, biotechnology, consumer products, chemicals and materials, technology, industrial goods, and packaging.

Fact.MR provides market intelligence designed to help organizations understand market dynamics, emerging opportunities, competitive developments, and changing industry requirements.

Media Contact

Fact.MR
Email: sales@factmr.com
Phone: +1 (628) 251-1583
Website: www.factmr.com